Hungarian pharmacovigilance functions are now within the National Center for Public Health and Pharmacy; legacy OGYÉI pages remain important sources and search aliases.
Core official resources
- Adverse drug reaction reporting — MAH EudraVigilance reporting context.
- Quality of ICSRs — national guidance highlighting common report-quality problems.
- EMA GVP.
Practical use
Hungary's authority explicitly focuses on the quality of structured ICSR fields and narratives because poor-quality submissions can impair signal detection. This makes the national ICSR-quality guidance useful for case-processing QA as well as regulatory compliance.